Tags: goldman sachsRemove, pharmaceuticalsRemove

The pharmaceutical company trades up 5.5% after pricing its $226.5 million IPO at the top of the range.
By Anette Jönsson | 23 April 2007
1
Tag Filters
Magazine
FinanceAsia Magazine
FinanceAsia
December 2011/January 2012